These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22528515)
1. Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer. Jin S; Zhu W; Shi Q; Zhang Z; Guo R Med Oncol; 2012 Dec; 29(5):3157-61. PubMed ID: 22528515 [TBL] [Abstract][Full Text] [Related]
2. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis]. Chang C; Wang P; Yang H; Li L; Zhang LB Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma. Radi DA; Abd-Elazeem MA Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161 [TBL] [Abstract][Full Text] [Related]
4. Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Faoro L; Hutto JY; Salgia R; El-Zayaty SA; Ferguson MK; Cheney RT; Reid ME; Armato SG; Krausz T; Husain AN Arch Pathol Lab Med; 2008 Dec; 132(12):1882-8. PubMed ID: 19061284 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and prognostic significance of podoplanin-positive lymphatic vessel density in non-small cell lung carcinoma]. Wang Y; Sun JG; Ye MF; Chen ZT Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):758-61. PubMed ID: 17327058 [TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of D2-40 in non-small cell lung cancer. Min KH; Park SJ; Lee KS; Hwang SH; Kim SR; Moon H; Han HJ; Chung MJ; Lee YC Lung; 2011 Feb; 189(1):57-63. PubMed ID: 21107593 [TBL] [Abstract][Full Text] [Related]
7. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ; Zhou QH; Zhang SF; Liu LX Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [TBL] [Abstract][Full Text] [Related]
8. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance. Fan C; Zhao Y; Liu D; Zhang X; Wang E Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980 [TBL] [Abstract][Full Text] [Related]
9. Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer. Zhang T; Nie J; Liu X; Han Z; Ding N; Gai K; Liu Y; Chen L; Guo C Clin Transl Sci; 2021 Jan; 14(1):389-394. PubMed ID: 33048433 [TBL] [Abstract][Full Text] [Related]
10. IL-17F expression correlates with clinicopathologic factors and biological markers in non-small cell lung cancer. Li C; Ma X; Tan C; Fang H; Sun Y; Gai X Pathol Res Pract; 2019 Oct; 215(10):152562. PubMed ID: 31387805 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer. Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404 [TBL] [Abstract][Full Text] [Related]
12. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. Wang XL; Fang JP; Tang RY; Chen XM BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772 [TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Li M; Chen H; Diao L; Zhang Y; Xia C; Yang F Tumori; 2010; 96(5):734-43. PubMed ID: 21302621 [TBL] [Abstract][Full Text] [Related]
14. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis]. Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer. Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683 [TBL] [Abstract][Full Text] [Related]
16. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
17. Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients. Zhao JQ; Sun FJ; Liu SS; Yang J; Wu YQ; Li GS; Chen QY; Wang JX Asian Pac J Cancer Prev; 2013; 14(2):639-43. PubMed ID: 23621211 [TBL] [Abstract][Full Text] [Related]
18. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry. Ci H; Xu Z; Xu J; Wang Y; Wu S Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593 [TBL] [Abstract][Full Text] [Related]
19. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point. Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680 [TBL] [Abstract][Full Text] [Related]
20. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis]. Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]